David A. Siegel Aura Biosciences, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 35,400 shares of AURA stock, worth $303,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,400
Previous 31,500
12.38%
Holding current value
$303,732
Previous $247,000
8.1%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AURA
# of Institutions
75Shares Held
40.4MCall Options Held
800Put Options Held
1.8K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$59.4 Million0.4% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$49.8 Million0.77% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.89MShares$41.9 Million0.07% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$26.1 Million8.2% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$25.8 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $251M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...